Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 27.48%460.73M | 60.72%135.49M | 96.56%121.88M | -13.26%106.6M | 4.95%96.77M | 52.91%361.41M | 84.3M | 62.01M | 122.89M | 92.21M |
| Cost of revenue | 20.73%281.57M | 95.58%79.74M | 95.40%76.8M | -31.57%63.13M | 1.66%61.89M | 36.58%233.22M | 40.77M | 39.31M | 92.26M | 60.88M |
| Gross profit | 39.77%179.16M | 28.07%55.74M | 98.57%45.08M | 41.89%43.46M | 11.33%34.88M | 95.42%128.19M | 43.53M | 22.7M | 30.63M | 31.33M |
| Operating expense | 39.01%35.7M | 110.84%249K | 7.20%10.22M | 102.47%14.69M | -5.81%10.54M | 90.45%25.68M | -2.3M | 9.54M | 7.25M | 11.19M |
| Selling and administrative expenses | 30.55%39.22M | 56.68%9.85M | 62.99%9.61M | 27.90%12.37M | -9.78%7.38M | 164.72%30.04M | --6.28M | --5.9M | --9.67M | --8.18M |
| -Selling and marketing expense | -23.68%2.93M | 143.36%898K | 5.23%443K | -11.17%1.15M | -74.82%443K | 93.16%3.84M | --369K | --421K | --1.29M | --1.76M |
| -General and administrative expense | 38.49%36.29M | 51.28%8.95M | 67.43%9.17M | 33.91%11.23M | 8.03%6.94M | 179.91%26.2M | --5.92M | --5.48M | --8.39M | --6.43M |
| Other operating expenses | 19.28%-3.52M | -11.83%-9.6M | -83.21%611K | 195.62%2.31M | 5.00%3.15M | -304.31%-4.36M | ---8.58M | --3.64M | ---2.42M | --3M |
| Operating profit | 39.96%143.47M | 21.10%55.49M | 164.75%34.86M | 23.09%28.77M | 20.86%24.34M | 96.70%102.51M | 45.82M | 13.17M | 23.38M | 20.14M |
| Net non-operating interest income (expenses) | 9.64%-2.11M | 62.99%-248K | 19.59%-476K | -5.78%-732K | -71.65%-654K | -131.42%-2.34M | -670K | -592K | -692K | -381K |
| Non-operating interest expense | -9.64%2.11M | -62.99%248K | -19.59%476K | 5.78%732K | 71.65%654K | 131.42%2.34M | --670K | --592K | --692K | --381K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 12.50%-7K | 0 | 0 | 0 | -40.00%-7K | 11.11%-8K | -2K | 2K | -3K | -5K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 11.89%-2.14M | 54.62%-638K | -876.06%-551K | -40.19%-865K | 82.80%-81K | -53.06%-2.42M | -1.41M | 71K | -617K | -471K |
| Income before tax | 42.43%139.21M | 24.83%54.61M | 167.49%33.83M | 23.17%27.18M | 22.38%23.6M | 97.41%97.74M | 43.75M | 12.65M | 22.06M | 19.29M |
| Income tax | 53.05%35.91M | 50.97%16.42M | 290.18%8.98M | -16.55%5.45M | 34.73%5.06M | 138.73%23.46M | 10.88M | 2.3M | 6.53M | 3.76M |
| Net income | 39.07%103.31M | 16.17%38.18M | 140.21%24.85M | 39.86%21.73M | 19.39%18.54M | 87.18%74.28M | 32.87M | 10.35M | 15.54M | 15.53M |
| Net income continuous operations | 39.07%103.31M | 16.17%38.18M | 140.21%24.85M | 39.86%21.73M | 19.39%18.54M | 87.18%74.28M | --32.87M | --10.35M | --15.54M | --15.53M |
| Noncontrolling interests | 5,417.02%2.5M | 27,692.31%3.59M | -11,463.64%-1.27M | 1,126.67%154K | 475.00%30K | -840.00%-47K | -13K | -11K | -15K | -8K |
| Net income attributable to the company | 35.62%100.81M | 5.22%34.6M | 152.24%26.12M | 38.73%21.58M | 19.14%18.51M | 87.27%74.33M | 32.88M | 10.36M | 15.55M | 15.54M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 35.62%100.81M | 5.22%34.6M | 152.24%26.12M | 38.73%21.58M | 19.14%18.51M | 87.27%74.33M | 32.88M | 10.36M | 15.55M | 15.54M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 19.77%0.126 | -17.42%0.0384 | 112.24%0.0312 | 32.89%0.0299 | 19.09%0.0262 | 36.45%0.1052 | 0.0465 | 0.0147 | 0.0225 | 0.022 |
| Diluted earnings per share | 19.77%0.126 | -17.42%0.0384 | 112.24%0.0312 | 32.89%0.0299 | 19.09%0.0262 | 36.45%0.1052 | 0.0465 | 0.0147 | 0.0225 | 0.022 |
| Dividend per share | 52.31%0.0428 | 0.0089 | -36.07%0.0078 | 0.0067 | 22.01%0.0194 | -17.35%0.0281 | 0 | 0.0122 | 0 | 0.0159 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.